Literature DB >> 21689613

Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma.

Asma Siddique1, Kris V Kowdley.   

Abstract

Coinciding with the increased incidence of hepatocellular carcinoma (HCC), there has been a significant increase in the global incidence of obesity and diabetes mellitus (DM), the two major risk factors for nonalcoholic steatohepatitis (NASH). There are many causes of HCC, and nonalcoholic fatty liver disease/NASH is now emerging as a leading risk factor owing to the epidemic of obesity and type 2 DM. The mechanisms leading to HCC in obesity and type 2 DM likely involve interactions between several signaling pathways, including oxidative stress, inflammation, oncogenes, adiponectins, and insulin resistance associated with visceral adiposity and diabetes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21689613      PMCID: PMC3874238          DOI: 10.1016/j.cld.2011.03.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  102 in total

1.  Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes.

Authors:  Hiroshi Hirose; Toshihide Kawai; Yukihiro Yamamoto; Matsuo Taniyama; Motowo Tomita; Koichi Matsubara; Yasunori Okazaki; Tatsuya Ishii; Yuko Oguma; Izumi Takei; Takao Saruta
Journal:  Metabolism       Date:  2002-03       Impact factor: 8.694

2.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

3.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

4.  Excess risk of primary liver cancer in patients with diabetes mellitus.

Authors:  H O Adami; W H Chow; O Nyrén; C Berne; M S Linet; A Ekbom; A Wolk; J K McLaughlin; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1996-10-16       Impact factor: 13.506

5.  Obesity and cancer risk: a Danish record-linkage study.

Authors:  H Møller; A Mellemgaard; K Lindvig; J H Olsen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

6.  Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3-L1 fibroblasts and adipocytes.

Authors:  D J Stumpo; P J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 7.  Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.

Authors:  Manjinder S Sandhu; David B Dunger; Edward L Giovannucci
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

Review 8.  The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Oliver Renner; Wolfgang Link; Juan F M Leal
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

9.  Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.

Authors:  Kohjiro Ueki; Tatsuya Kondo; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity.

Authors:  Atsushi Tsuchida; Toshimasa Yamauchi; Yusuke Ito; Yusuke Hada; Toshiyuki Maki; Sato Takekawa; Junji Kamon; Masaki Kobayashi; Ryo Suzuki; Kazuo Hara; Naoto Kubota; Yasuo Terauchi; Philippe Froguel; Jun Nakae; Masato Kasuga; Domenico Accili; Kazuyuki Tobe; Kohjiro Ueki; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

View more
  17 in total

Review 1.  Hepatitis C virus infection and insulin resistance.

Authors:  Sandip K Bose; Ranjit Ray
Journal:  World J Diabetes       Date:  2014-02-15

2.  Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.

Authors:  Mustafa Akker; Sibel Güldiken; Tammam Sipahi; Orkide Palabıyık; Ayhan Tosunoğlu; Özlem Çelik; Nermin Tunçbilek; Atakan Sezer; Necdet Süt
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

Review 3.  Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.

Authors:  Letiția Adela Maria Streba; Cristin Constantin Vere; Ion Rogoveanu; Costin Teodor Streba
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis.

Authors:  Karen D Corbin; Manal F Abdelmalek; Melanie D Spencer; Kerry-Ann da Costa; Joseph A Galanko; Wei Sha; Ayako Suzuki; Cynthia D Guy; Diana M Cardona; Alfonso Torquati; Anna Mae Diehl; Steven H Zeisel
Journal:  FASEB J       Date:  2013-01-04       Impact factor: 5.191

Review 5.  Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.

Authors:  Javier Ampuero; Manuel Romero-Gomez
Journal:  World J Hepatol       Date:  2015-05-18

Review 6.  Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.

Authors:  Chun-Meng Jiang; Chun-Wen Pu; Ya-Hui Hou; Zhe Chen; Mohammed Alanazy; Lionel Hebbard
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores.

Authors:  Yan Huang; Lichang Chen; Rui Huang; Chuanwu Zhu; Jia Shang; Yunsong Qian; Jianqi Lian; Longgen Liu; Jianning Jiang; Chenghai Liu; Honglian Gui; Qing Xie
Journal:  Ther Adv Chronic Dis       Date:  2022-06-21       Impact factor: 4.970

Review 8.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 9.  Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know.

Authors:  Victoria E R Parker; Robert K Semple
Journal:  Eur J Endocrinol       Date:  2013-09-12       Impact factor: 6.664

10.  Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Jiangguo Zhang; Fengyun Gong; Ling Li; Manzhi Zhao; Jianxin Song
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.